4//SEC Filing
Young Joseph R 4
Accession 0001415889-24-013504
CIK 0001831828other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:21 PM ET
Size
19.1 KB
Accession
0001415889-24-013504
Insider Transaction Report
Form 4
Young Joseph R
SVP, FINANCE, CHIEF ACCT OFFCR
Transactions
- Sale
Class A Common Stock
2024-05-15$42.17/sh−8,221$346,680→ 53,171 total - Sale
Class A Common Stock
2024-05-15$42.68/sh−1,965$83,866→ 51,206 total - Exercise/Conversion
Class A Common Stock
2024-05-16$7.87/sh+18,151$142,848→ 69,357 total - Sale
Class A Common Stock
2024-05-16$42.22/sh−18,151$766,317→ 51,206 total - Exercise/Conversion
Stock Option (right to buy)
2024-05-15−8,221→ 58,589 totalExercise: $3.94Exp: 2031-04-13→ Class A Common Stock (8,221 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-05-16−20,651→ 69,349 totalExercise: $7.87Exp: 2033-02-14→ Class A Common Stock (20,651 underlying) - Exercise/Conversion
Class A Common Stock
2024-05-16$7.87/sh+2,500$19,675→ 53,706 total - Sale
Class A Common Stock
2024-05-16$43.03/sh−2,500$107,573→ 51,206 total - Exercise/Conversion
Class A Common Stock
2024-05-15$3.94/sh+8,221$32,387→ 61,392 total
Footnotes (4)
- [F1]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.86, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.01 to $43.08, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter.
- [F4]1/48 of the total stock option vests and becomes exercisable monthly on the same day of each month following February 15, 2023, subject to continuous service of the Reporting Person on each vesting date.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001861684
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:21 PM ET
- Size
- 19.1 KB